Papers

7

Total Citations

164

H-Index

5

About

Jack Grierson is a leading urological surgeon and researcher whose work focuses on improving functional outcomes for men undergoing robot-assisted radical prostatectomy (RARP) for localized prostate cancer. His major contributions center on the NeuroSAFE technique—a standardized intraoperative frozen section analysis that enables real-time detection of positive margins during nerve-sparing surgery. Through the landmark NeuroSAFE PROOF trial, Grierson and his team demonstrated that this approach significantly improves postoperative erectile function and early urinary continence recovery without compromising oncological control. The phase 3 results, published in 2025, have already garnered 39 citations and represent a paradigm shift in surgical precision. His earlier feasibility study (46 citations) established the safety and histopathological concordance of the technique. Grierson has also advanced preoperative staging, showing that negative multiparametric MRI can reliably rule out extra-prostatic extension, helping to avoid unnecessary nerve resection. With over 160 cumulative citations across his key publications, Grierson’s work bridges surgical innovation and patient quality of life, offering men with prostate cancer a better chance at preserving sexual and urinary function after curative treatment.

Research Focus

Key Achievements

5
H-Index
7
Papers
164
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
NeuroSAFE frozen section during robot‐assisted radical prostatectomy: peri‐operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trial
46 citations · 2020
📈 Most Prolific Year: 2022 (4 Papers)
🤝 Key Collaborators: 63
🏛 Institutions: University College London, University College Hospital, University College Hospital at Westmoreland Street

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago